Efficacy and tolerability of a double boosted protease inhibitor (lopinavir + saquinavir/ritonavir) regimen in HIV-infected patients who failed treatment with nonnucleoside reverse transcriptase inhibitors

• Main Authors: P. Chetchotisakd, S. Anunnatsiri, P. Mootsikapun, S. Kiertiburanakul, T. Anekthananon, C. Bowonwatanuwong, B. Kowadisaiburana, K. Supparatpinyo, K. Ruxrungtham
• Format: Journal
• Published: 2018
• Subjects: Medicine
• Online Access: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=35448967037&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/61246
• Institution: Chiang Mai University

Objectives: Long-term nonnucleoside reverse transcriptase inhibitor (NNRTI)-based antiretroviral treatment failure in most developing countries has led to broad cross-resistance within NNRTI and nucleoside reverse transcriptase inhibitor (NRTI) classes. In this study, we investigated the efficacy an...